Dr. Reddy’s Methylphenidate Hydrochloride Extended-Release Tablets, USP are available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100.

BRIDGEWATER, N.J., Feb. 5, 2018 /PRNewswire/ -- Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths. Amneal's ...

Dr. Reddy’s is offering methylphenidate hydrochloride extended-release tablets, in dosage strengths of 18 mg, 27 mg, 36 mg and 54 mg. The product is the generic of Janssen’s Concerta ...

Pfizer announced that the FDA has approved QuilliChew ER (methylphenidate HCl extended-release) chewable tablets for the treatment of ADHD in patients aged ≥6 years.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and ...

Mallinckrodt also plans to submit a supplement to its approved abbreviated new drug application for Methylphenidate HCl 18mg in the first quarter of 2013. For more information call (888) 744-1414 ...

Careful follow-up of weight and height in pediatric patients ages 7 to 10 years who were randomized to either methylphenidate or non-medication treatment groups over 14 months, as well as in ...

Sun Pharma has yanked one lot of 20 mg Methylphenidate Hydrochloride tablets. The 7,313 100-count bottles in lot No. AC74459 with expiration date 07/31/2024 were distributed nationwide.

Pfizer Announces Availability Of Quillivant XR™ (methylphenidate hydrochloride) CII For Extended-Release Oral Suspension In The United States The First Once-Daily, Extended-Release Liquid ...

Although methylphenidate hydrochloride (MPH) is a first-line treatment for children with attention-deficit hyperactivity disorder (ADHD), the non-response rate is 30%. Our aim was to develop a ...